Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Knee Hyaluronic Acid Injections Market Forecast Highlighting Growth From $3.37 Billion To $4.35 Billion
The knee hyaluronic acid injections market size has experienced strong growth in recent years. It is forecasted to increase from $3.17 billion in 2025 to $3.37 billion in 2026, with a compound annual growth rate (CAGR) of 6.4%. The expansion witnessed in the historic period stems from the rising prevalence of osteoarthritis, an increasing geriatric population, the growing adoption of viscosupplementation therapies, the expansion of hospital-based orthopedic treatments, and limited historical surgical alternatives.
The knee hyaluronic acid injections market size is anticipated to undergo significant expansion in the coming years. It is projected to grow to $4.35 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.6%. This growth during the forecast period is attributable to advancements in hyaluronic acid formulation technologies, the increasing demand for minimally invasive joint treatments, rising healthcare expenditure on orthopedic care, the expansion of outpatient and ambulatory surgical infrastructure, and a growing focus on regenerative and biological therapies. Prominent trends observed in this period include the rising adoption of single-injection viscosupplementation for osteoarthritis, an increasing preference for minimally invasive orthopedic therapies, a growing geriatric population driving demand for osteoarthritis treatment, the expansion of outpatient orthopedic and ambulatory care settings, and increased clinical research on hyaluronic acid molecular weight efficacy.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample_request?id=32214837&type=smp
#Knee Hyaluronic Acid Injections Market Growth Drivers And Industry Catalysts
The increasing occurrence of obesity is projected to boost the expansion of the knee hyaluronic acid injections market in the future. Obesity is a health condition marked by an excessive buildup of body fat, posing health risks, and typically assessed using the body mass index (BMI). The prevalence of obesity is on the rise, attributed to inactive lifestyles and decreased physical activity, both of which contribute to unhealthy weight gain and related health issues. Knee hyaluronic acid injections offer a solution for managing osteoarthritis symptoms in obese individuals by restoring joint lubrication, reducing inflammation, and enhancing movement. For example, in May 2025, data from the Office for Health Improvement and Disparities, a UK government body, revealed that between 2023 and 2024, an estimated 64.5% of adults aged 18 and above in England were categorized as overweight or obese, marking a slight increase from the 64.0% reported in 2022–2023. Consequently, the growing incidence of obesity is fueling growth in the knee hyaluronic acid injections market. The growing prevalence of knee osteoarthritis (OA) is anticipated to fuel the expansion of the knee hyaluronic acid injections market moving forward. Knee osteoarthritis (OA) is a degenerative joint condition characterized by the gradual deterioration of cartilage within the knee joint, resulting in pain, stiffness, and limited mobility. The incidence of knee osteoarthritis is increasing due to an aging global population, rising obesity rates, sedentary habits, and a greater occurrence of joint injuries. Knee hyaluronic acid injections assist in alleviating knee osteoarthritis symptoms by improving joint lubrication, decreasing pain and inflammation, and enhancing mobility and overall joint function. As an illustration, in August 2024, the World Health Organization (WHO), an intergovernmental organization based in Switzerland, reported that approximately 365 million people worldwide were living with knee osteoarthritis in 2023, with its prevalence continuing to grow due to an aging population and increasing obesity levels. Therefore, the rising prevalence of knee osteoarthritis (OA) is driving demand in the knee hyaluronic acid injections market.
Knee Hyaluronic Acid Injections Market Segment Outlook: Which Categories Are Expanding The Fastest?
The knee hyaluronic acid injections market covered in this report is segmented –
1) By Product Type: Single Injection, Three Injection, Five Injection
2) By Indication: Knee Osteoarthritis, Ligament Injury, Post Arthroscopy, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By Application: Osteoarthritis, Rheumatoid Arthritis, Other Applications
5) By End User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Single Injection: Cross-Linked Hyaluronic Acid Injections, Non-Cross-Linked Hyaluronic Acid Injections, High Molecular Weight Hyaluronic Acid Injections, Low Molecular Weight Hyaluronic Acid Injections, Visco supplementation Hyaluronic Acid Injections
2) By Three Injection: Cross-Linked Hyaluronic Acid Injections, Non-Cross-Linked Hyaluronic Acid Injections, High Molecular Weight Hyaluronic Acid Injections, Low Molecular Weight Hyaluronic Acid Injections, Visco supplementation Hyaluronic Acid Injections
3) By Five Injection: Cross-Linked Hyaluronic Acid Injections, Non-Cross-Linked Hyaluronic Acid Injections, High Molecular Weight Hyaluronic Acid Injections, Low Molecular Weight Hyaluronic Acid Injections, Visco supplementation Hyaluronic Acid Injections
#Knee Hyaluronic Acid Injections Market Trends Influencing Long-Term Demand
Leading companies in the knee hyaluronic acid injections market are concentrating on developing advanced therapies, such as single-injection HA knee treatments. These innovations aim to restore synovial fluid viscosity, reduce pain, and improve joint function with a single intra-articular administration, as opposed to multiple injections. A single-injection HA knee treatment describes a medical procedure where one dose of hyaluronic acid (HA) is administered into the knee joint to alleviate pain and enhance mobility, typically for individuals with osteoarthritis. For example, in July 2024, LG Chem, a South Korea-based life sciences and pharmaceutical company, introduced Synovian (branded in China as Hyruan ONE), a cross-linked hyaluronic acid injection for knee osteoarthritis in the Chinese market. This product provides therapeutic benefits comparable to multi-injection regimens, simplifies treatment to a single visit, and proved safe and efficacious in Phase-3 clinical trials among Chinese patients. Synovian’s single-dose convenience, its cross-linked HA formulation designed for longer intra-articular residence, and its inclusion on China’s National Reimbursement Drug List collectively support broader adoption and enhanced patient compliance, although physician training and insurance uptake vary across regions.
Knee Hyaluronic Acid Injections Market Key Companies And Competitive Benchmarking
Major companies operating in the knee hyaluronic acid injections market are Johnson & Johnson, Sanofi S. A., Teva Pharmaceutical Industries Ltd., Smith & Nephew plc, Chugai Pharmaceutical Co. Ltd., Zimmer Biomet Holdings Inc., Bioventus Inc., Fidia Farmaceutici S. p. A., Ferring Pharmaceuticals A/S, IBSA Institut Biochimique SA, Anika Therapeutics Inc., Lifecore Biomedical LLC, TRB Chemedica International S. A., Seikagaku Corporation, Hangzhou Singclean Medical Products Co. Ltd., Virchow Biotech Private Limited, OrthogenRx Inc., Shanghai Haohai Biological Technology Co. Ltd., Allergan plc, Shandong Freda Biochem Co. Ltd.
Access The Complete Knee Hyaluronic Acid Injections Market Report:
https://www.thebusinessresearchcompany.com/report/knee-hyaluronic-acid-injections-market-report
Knee Hyaluronic Acid Injections Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the knee hyaluronic acid injections market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the knee hyaluronic acid injections market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.